About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
Update on Treatment Options for Ovarian Germ Cell Tumors: BEP Chemotherapy as the Current Standard, Fertility-Sparing Surgery & Active Surveillance Programme
By
Baltic and Eurasia Masterclass in Clinical Oncology
FEATURING
Maria Del Grande
By
Baltic and Eurasia Masterclass in Clinical Oncology
FEATURING
Maria Del Grande
222 views
August 23, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
19:30
AstraZeneca Oncology
The Importance of HRD Testing in Advanced Ovarian Cancer
Feat.
M. Markman
Featured Video
11:42
ImmunoGen
Best Practices for the management of ocular adverse events associate…
Feat.
K. Lamoreau
Related Content
AUTOPLAY
ON
09:06
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecologic Oncology Updates"
Feat.
R. Salani
14:45
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Gynecological Cancers Highlights"
Feat.
M. Raza Mirza
11:15
Total Health
2024 Updates in Ovarian Cancer
Feat.
T. Tillmanns
13:15
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Timing of Debulking Surgery in Advanced En…
Feat.
A. Karam
15:45
Michael Birrer
Defining Platinum Resistance in Ovarian Cancer
27:14
David Tan
Management of Recurrent Ovarian Clear Cell Carcinoma
06:50
Fengting Yan
Year in Review: Ovarian Cancer
19:30
Miami Cancer Institute Precision Oncology Symposium
Precision Oncology in the Management of Ovarian Cancer
Feat.
D. Dizon
25:10
Yale School of Medicine
Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …
Feat.
M. Minkin,
E. Ratner
23:53
Masonic Cancer Center, University of Minnesota
Overview of Ovarian Cancer Updates
Feat.
J. Mattson
12:56
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: Options for Recurrent Platinum…
Feat.
H. Cun
18:16
Insights from 2024 ESGO Annual Meeting
ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…
Feat.
J. Kurtz
06:23
Total Health
Recent Highlights in Ovarian Cancer
Feat.
B. Slomovitz
23:46
AstraZeneca Oncology
First-line Maintenance Treatment Option in Patients With HRD-Positiv…
Feat.
S. Lewin
17:33
AstraZeneca Oncology
First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…
Feat.
S. Lewin
13:01
Richard Penson
Treatment Options for Platinum-Sensitive Recurrent Ovarian Cancer
20:09
AstraZeneca Oncology
Management Strategies for Anemia in First-line Maintenance Therapy f…
Feat.
D. Czel,
C. Arn
03:55
Insights from 2024 SGO Annual Meeting
SGO 2024 Insights: "COMB1NE Study - Characteristics and Real-Wo…
Feat.
P. Thaker
28:11
OncoAlert
Ovarian Cancer: Setting a New Standard of Care
Feat.
M. Raza Mirza
05:32
Insights from 2023 ESMO Asia Annual Meeting
LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…
Feat.
N. Ngoi
